Concert Pharmaceuticals, Inc.
CNCEDelisted Mar 6, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001367920
Concert Pharmaceuticals, Inc. was delisted on Mar 6, 2023; its insiders filed their last Form 4 on Mar 6, 2023; 85 institutions reported holding it in 13F filings for Q4 2022, worth $207.2M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Concert Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 53 | 70 | +17 |
| Shares | 17.2M | 30.1M | +12.9M (+74.8%) |
| Value | $58.0M | $126.5M | +$68.6M (+118.3%) |
New holders (23)
Institutions that held Concert Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
Sold out (6)
Institutions that held Concert Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Charles Schwab Investment Management Inc | 23,681 | $80.0K |
| Jane Street Group, LLC | 16,627 | $56.0K |
| Susquehanna International Group, LLP | 15,476 | $52.0K |
| HRT Financial LP | 14,470 | $48.0K |
| Federated Hermes, Inc. | 239 | $1.00K |
| De Burlo Group Inc | 200 | $674 |